Ignite Creation Date:
2024-05-05 @ 6:30 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00490139
Status:
COMPLETED
Last Update Posted:
2021-07-23
First Post:
2007-06-20
Brief Title:
ALTTO Adjuvant Lapatinib AndOr Trastuzumab Treatment Optimisation Study BIG 2-06N063D
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
EGF106708
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Canadian Cancer Trials Group | NETWORK |
| North Central Cancer Treatment Group | NETWORK |
| National Cancer Institute NCI | NIH |
| Breast International Group | OTHER |